These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21206231)

  • 1. Intraocular lymphoma and central nervous system lymphoma involving the hypothalamus: staging and evaluation of response to therapy with F-18 FDG PET/CT.
    Makis W; Novales-Diaz JA; Hickeson M
    Clin Nucl Med; 2010 Dec; 35(12):956-9. PubMed ID: 21206231
    [No Abstract]   [Full Text] [Related]  

  • 2. The management of pyothorax-associated lymphoma using 18F-FDG PET/CT.
    Ito K; Shida Y; Kubota K; Morooka M; Aruga T; Itami J; Matsuda H
    Ann Nucl Med; 2010 Nov; 24(9):649-54. PubMed ID: 20740330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of FDG-PET/CT in the management of lymphoma.
    Baba S; Abe K; Isoda T; Maruoka Y; Sasaki M; Honda H
    Ann Nucl Med; 2011 Dec; 25(10):701-16. PubMed ID: 22037934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT for therapy response assessment in lymphoma.
    Hutchings M; Barrington SF
    J Nucl Med; 2009 May; 50 Suppl 1():21S-30S. PubMed ID: 19380407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET-CT in the management of primary breast lymphoma.
    Santra A; Kumar R; Reddy R; Halanaik D; Kumar R; Bal CS; Malhotra A
    Clin Nucl Med; 2009 Dec; 34(12):848-53. PubMed ID: 20139815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of functional imaging in the management of lymphoma.
    Cheson BD
    J Clin Oncol; 2011 May; 29(14):1844-54. PubMed ID: 21482982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of advanced non-Hodgkin's lymphoma involving the prostate: staging and treatment monitoring using F-18 FDG PET/CT imaging.
    Cimarelli S; Lachenal F; Ricard F; Chassagne-Clément C; Heudel PE; Janody P; Sebban C
    Clin Nucl Med; 2010 Jun; 35(6):425-7. PubMed ID: 20479591
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 18F-FDG positron emission tomography and computed tomography in patients with colorectal carcinoma and lymphoma: our initial clinical experience.
    Coha B; Radmilović K; Gardasanić J; Daković M; Stefanić M; Latić A; Mitrecić D
    Acta Clin Croat; 2009 Mar; 48(1):35-9. PubMed ID: 19623870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI and PET in monitoring response in lymphoma.
    Rahmouni A; Luciani A; Itti E
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S106-12. PubMed ID: 16361125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
    Karantanis D; O'Neill BP; Subramaniam RM; Peller PJ; Witte RJ; Mullan BP; Wiseman GA
    Clin Nucl Med; 2007 Apr; 32(4):271-4. PubMed ID: 17413571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
    Kasamon YL; Jones RJ; Wahl RL
    J Nucl Med; 2007 Jan; 48 Suppl 1():19S-27S. PubMed ID: 17204717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
    Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
    Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma.
    Lodde M; Lacombe L; Friede J; Morin F; Saourine A; Fradet Y
    BJU Int; 2010 Sep; 106(5):658-63. PubMed ID: 20151968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG PET/CT flip flop phenomenon in treated lymphoma of bone.
    Lin EC
    Clin Nucl Med; 2006 Dec; 31(12):803-5. PubMed ID: 17117078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
    Chong EA; Torigian DA; Mato AR; Downs LH; Schuster SJ
    Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
    J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
    J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative CT analysis for assessing response in lymphoma (Cheson's criteria).
    Rahmouni A; Luciani A; Itti E
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S102-6. PubMed ID: 16361124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.
    Picchio M; Mangili G; Samanes Gajate AM; De Marzi P; Spinapolice EG; Mapelli P; Giovacchini G; Sigismondi C; Viganò R; Sironi S; Messa C
    Nucl Med Commun; 2010 Jun; 31(6):506-12. PubMed ID: 20168262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.